Growth Metrics

Pharma-Bio Serv (PBSV) Short-Term Debt issuances (2020)

Pharma-Bio Serv posted quarterly Short-Term Debt issuances of $1.9 million for Q2 2020.

Pharma-Bio Serv (PBSV) has 1 years of Short-Term Debt issuances data on file, last reported at $1.9 million in Q2 2020.

  • For the quarter ending Q2 2020, Short-Term Debt issuances changed N/A year-over-year to $1.9 million; the trailing twelve-month figure through Apr 2021 stood at $1.9 million (changed N/A YoY), and the FY2020 full-year result was $1.9 million, changed N/A from the prior year.
  • Short-Term Debt issuances for Q2 2020 stood at $1.9 million.
  • Across five years, Short-Term Debt issuances topped out at $1.9 million in Q2 2020 and bottomed at $1.9 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn -
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Pharma-Bio Serv - - 722,374.00 -

Historic Data

Download Data 🔒
DateValue
Apr 30, 2020 1.93 Mn
Apr 30, 2020 1.93 Mn